Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Biogen Idec up on Icahn news

BIIB gained $2.92 to $62.89 on Friday after

Read the full 86 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE